Skip to content
Patients
HCPs
X-twitter Instagram Youtube Icon-mail Tiktok
Follow on X
Home
Daily Updates

Categories

Who may omit locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: a failure-pattern-based strategy in the immunotherapy era.

  • Post category:Head & Neck Cancers
  • Reading time:2 mins read

This retrospective real-world study analyzed 398 patients with de novo metastatic nasopharyngeal carcinoma treated with...

Continue ReadingWho may omit locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: a failure-pattern-based strategy in the immunotherapy era.

Circulating Human Papillomavirus DNA-Liquid Biopsy in Head and Neck Cancers.

  • Post category:Head & Neck Cancers
  • Reading time:2 mins read

This publication reviews the current evidence on circulating tumor HPV DNA (ctHPVDNA) as a liquid biopsy tool in human p...

Continue ReadingCirculating Human Papillomavirus DNA-Liquid Biopsy in Head and Neck Cancers.

Percutaneous endoscopic gastrostomy improves survival and nutritional outcomes in patients with head and neck cancer.

  • Post category:Head & Neck Cancers
  • Reading time:1 min read

This retrospective cohort study evaluated the impact of percutaneous endoscopic gastrostomy (PEG) on patients with head...

Continue ReadingPercutaneous endoscopic gastrostomy improves survival and nutritional outcomes in patients with head and neck cancer.

Achieving control of nasopharyngeal carcinoma: the role of Epstein-Barr virus-based screening and vaccines.

  • Post category:Head & Neck Cancers
  • Reading time:1 min read

This review focuses on nasopharyngeal carcinoma (NPC), particularly in regions where it is endemic and closely linked to...

Continue ReadingAchieving control of nasopharyngeal carcinoma: the role of Epstein-Barr virus-based screening and vaccines.

Neoadjuvant tislelizumab with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-1): a phase 2 clinical trial.

  • Post category:Head & Neck Cancers
  • Reading time:1 min read

This phase II neoCHANCE-1 study evaluated neoadjuvant dual blockade of PD-1 and EGFR pathways using tislelizumab and afa...

Continue ReadingNeoadjuvant tislelizumab with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-1): a phase 2 clinical trial.

HPV Workshop for Underserved High School Students.

  • Post category:Head & Neck Cancers
  • Reading time:1 min read

This study addresses the rising incidence of HPV-related oropharyngeal cancer and persistent disparities in HPV vaccinat...

Continue ReadingHPV Workshop for Underserved High School Students.
  • © Together4Cancer. All rights reserved.
  • Privacy Policy
  • Terms of Use